SCHEMBL7705947

SCHEMBL7705947

Cc1ccc(-c2cc(N)n3nc(-c4cccs4)nc3c2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.54
ALDH1A1 P00352 9/20 0.48
KDM4E B2RXH2 8/20 0.48
LMNA P02545 4/20 0.48
KMT2A Q03164 4/20 0.48
MAPT P10636 4/20 0.48
MEN1 O00255 3/20 0.48
TP53 P04637 2/20 0.48
CYP2C19 P33261 1/20 0.48
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
HPGD P15428 5/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
GAA P10253 1/20 0.47
NFKB1 P19838 3/20 0.43
NFKB2 Q00653 3/20 0.43
RELA Q04206 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPK1 P28482 1/20 0.43
ADK P55263 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708740 0.89 ADORA2A (0.57) ADORA2AALDH1A1KDM4EKMT2AMAPT
SCHEMBL7708573 0.88 ADORA2A (0.52) ADORA2AALDH1A1KDM4ELMNAKMT2A
SCHEMBL7432234 0.88 ADORA2A (0.56) ADORA2AALDH1A1KDM4EKMT2AMEN1
SCHEMBL7705971 0.87 ADORA2A (0.51) ADORA2AALDH1A1KDM4ELMNAKMT2A
SCHEMBL7709150 0.83 ADORA2A (0.54) ADORA2AALDH1A1KDM4ELMNAKMT2A
SCHEMBL7708503 0.81 NPC1 (0.53) ADORA2AALDH1A1KDM4ELMNAKMT2A
SCHEMBL7711729 0.79 ADORA2A (0.52) ADORA2AALDH1A1KDM4ELMNAKMT2A
SCHEMBL7709012 0.78 ADORA2A (0.49) ADORA2AALDH1A1KDM4ELMNAKMT2A
SCHEMBL7480280 0.78 ADORA2A (0.59) ADORA2AALDH1A1KDM4ELMNAKMT2A
SCHEMBL7705871 0.77 FYN (0.55) ADORA2AALDH1A1KDM4EKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed